My WebLink
|
Help
|
About
|
Sign Out
ORD 2218
City of Pleasanton
>
CITY CLERK
>
ORDINANCES
>
2201 - 2300
>
ORD 2218
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
6/30/2023 4:22:55 PM
Creation date
7/23/2021 10:07:21 AM
Metadata
Fields
Template:
CITY CLERK
CITY CLERK - TYPE
ORDINANCES
DOCUMENT DATE
7/20/2021
DESTRUCT DATE
PERMANENT
Tags
Ordinance
Description:
Ordinance
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
44
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
ORDINANCE NO. 2218 <br /> AN ORDINANCE OF THE CITY COUNCIL OF THE CITY OF PLEASANTON <br /> APPROVING A DEVELOPMENT AGREEMENT BETWEEN THE CITY OF <br /> PLEASANTON AND 10X GENOMICS, INC. <br /> WHEREAS, Government Code §§65865-65869.5 authorizes a city to enter into binding <br /> development agreements with persons having legal interests in real property for the development <br /> of such property; and <br /> WHEREAS, 10x Genomics, Inc. has applied to the City for a Development Agreement <br /> concerning its PUD rezoning and development plan applications for a Planned Unit Development <br /> (PUD) Rezoning to rezone the subject parcel from C-R (p) (Regional Commercial - peripheral <br /> sites) District to PUD-C-O (Planned Unit Development— Commercial-Office) District and a PUD <br /> Development Plan to construct up to three new multi-story research and development, office and <br /> laboratory buildings totaling approximately 381,000 square feet, a parking structure, and related <br /> site improvements over multiple phases at its 1701 Springdale Avenue property, referred to as <br /> PUD-139 and P20-0973 (collectively the "Project"); and <br /> WHEREAS, after public notice, on May 25, 2021, the Planning Commission held a hearing <br /> and recommended that the City Council make a finding of General Plan conformity for the <br /> Development Agreement; and <br /> WHEREAS, at its meeting of June 15, 2021, the City Council reviewed the agenda report <br /> from the Director of Community Development together with a copy of the agenda report to the <br /> Planning Commission on this matter, and held duly-noticed public hearing, at which time 10x <br /> Genomics, Inc. and members of the public were offered an opportunity to present evidence <br /> regarding the development agreement; and <br /> WHEREAS, the development agreement is for the Project for which the City Council <br /> adopted a Mitigated Negative Declaration on June 15, 2021. <br /> NOW, THEREFORE, THE CITY COUNCIL OF THE CITY OF PLEASANTON DOES <br /> HEREBY ORDAIN AS FOLLOWS: <br /> SECTION 1. Finds that the proposed development agreement is consistent with the <br /> City's General Plan. <br /> SECTION 2. Approves the Development Agreement between the City of Pleasanton and <br /> 10x Genomics, Inc., a copy of which is attached hereto as Exhibit A and incorporated herein by <br /> this reference, and authorizes the City Manager to sign the Development Agreement in generally <br /> the form shown in Exhibit A, subject to minor modifications approved by the City Manager and <br /> City Attorney. <br /> SECTION 3. A summary of this ordinance shall be published once within fifteen (15) <br /> days after its adoption in "The Valley Times," a newspaper of general circulation published in the <br /> City of Pleasanton, and the complete ordinance shall be posted for fifteen (15) days in the City <br /> Clerk's office within fifteen (15) days after its adoption. <br />
The URL can be used to link to this page
Your browser does not support the video tag.